Kadans Science Partner will add Windrush Innovation Center in Oxford, UK to its Pan-European portfolio. The asset will be freehold acquired from Tozi Limited. Kadans intends to demolish the existing building and create over 60,000 square feet of new high specification laboratory and office space in partnership with the tenant, Oxford Biomedica.

With the acquisition of Windrush Innovation Centre, the Kadans portfolio now comprises of over 50 buildings and numerous projects under development in the Netherlands, United Kingdom, Germany, Belgium, France, and Spain. Kadans aspires to partner with universities, venture capital firms and innovative organizations to create one strong knowledge-sharing ecosystem of scientific enterprise across Europe.

James Sheppard, managing director (UK & Ireland) Kadans said: “We are delighted to continue to be building our portfolio in Oxford. The development at Windrush Innovation Center will provide much needed, high specification, laboratory space in the Oxford market. We look forward to a continued productive relationship with the tenant, Oxford Biomedica, as they build their position as a quality and innovation-led viral vector CDMO.”

In a statement Tozi Limited said, “In keeping with our approach across our entire portfolio, we have always maintained a productive and open relationship with the tenant Oxford Biomedica, helping to facilitate planning permission for the brand-new state of the art R&D campus.”